跳至主要内容
临床试验/ACTRN12615000862549
ACTRN12615000862549已完成未知

The use of MRI in radiotherapy planning to assess the feasibility of adaptive radiotherapy in gynaecological cancers.

Dr Karen Lim0 个研究点目标入组 32 人开始时间: 2015年8月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Eligible patients will have a gynaecological cancer for which they have been recommended a course of radiotherapy to the pelvis, in addition to:
  • 1. Aged older than 18 years
  • 2. ECOG 0-3
  • 3. Histological diagnosis of malignant gynaecological tumour, including
  • a. Squamous cell carcinoma
  • b. Adenocarcinoma
  • c. Adenosquamous cell carcinoma
  • d. Endometrial carcinoma
  • e. Melanoma
  • f. Malignant mesenchymal tumours
  • g. Undifferentiated carcinomas
  • 4. Written informed consent

排除标准

  • 1. Contraindication for MRI
  • a. Cardiac pacemaker or defibrillator
  • b. Non MRI compatible implants
  • i.Metal rod, screw or plate
  • ii Aneurysm clip
  • iii Artificial heart valve
  • iv Cochlear implant
  • v Intravascular stent
  • c. Non-MRI compatible metallic foreign body
  • i Metallic fragment in the eye
  • ii Bullet or shrapnel injury
  • d. Severe claustrophobia
  • 2. Prior hysterectomy
  • 3. Women who are pregnant and the human foetus
  • 4. Children and/or young people (ie. <18 years)
  • 5. People with an intellectual or mental impairment
  • 6. People highly dependent on medical care

研究者

发起方
Dr Karen Lim

相似试验

Developing methods to allow adaptive radiotherapy... | 临床试验